HomeHRTIS • HEL
add
Herantis Pharma Oyj
Previous close
€1.51
Day range
€1.47 - €1.54
Year range
€1.17 - €1.88
Market cap
30.64M EUR
Avg Volume
18.12K
P/E ratio
-
Dividend yield
-
Primary exchange
HEL
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.38M | 14.45% |
Net income | -1.34M | -49.69% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.49M | -28.93% |
Total assets | 3.65M | -29.04% |
Total liabilities | 1.61M | -77.02% |
Total equity | 2.04M | — |
Shares outstanding | 20.16M | — |
Price to book | 15.10 | — |
Return on assets | -94.44% | — |
Return on capital | -166.42% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -1.34M | -49.69% |
Cash from operations | -1.52M | -76.76% |
Cash from investing | -237.00K | -178.09% |
Cash from financing | -2.50K | -600.00% |
Net change in cash | -1.76M | -216.58% |
Free cash flow | -862.50K | -13.30% |
About
Founded
2008
Website
Employees
11
